Predilife (XPAR:ALPRE) FFO


XPAR:ALPRE Predilife SA XPAR:ALPRE
32 GF Score
Price €1.90
GF Value €18.98
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Predilife FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:ALPRE
32GF Score
Predilife SA XPAR:ALPRE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Predilife (XPAR:ALPRE) Overvalued in 2026?

Based on GuruFocus' analysis, Predilife stock appears to be undervalued. The current stock price of €1.90 is trading 90% below its estimated GF Value™ of €18.98. GuruFocus considers Predilife to be Possible Value Trap.

Key valuation signals for XPAR:ALPRE:

  • FFO:
  • GF Value™: €18.98 vs. price of €1.90 (90% below fair value)
  • GF Score™: 32/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALPRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Predilife Business Description

Other Exchanges 0GA:Germany
Address 39 rue Camille Desmoulins, Villejuif, Villejuif, FRA, 94805
Predilife SA develops solutions for predictive medicine, combining medical techniques (genetic tests, medical imaging) and mathematical models with a large amount of statistical data, which allows each individual to define their risk profile for the occurrence of various serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
32GF Score

Get the complete analysis for XPAR:ALPRE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.90
Price
€18.98
GF Value